🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III multi-center, double-masked, vehicle-controlled, random...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02492321
Treatments Being Tested
Study to evaluate the safety and tolerability of MC-1101, a potential topic...
Status
Completed
Location
Sall Eye Center
Start Date
2013-09
Trial ID
NCT01922128
Treatments Being Tested
This clinical trial is designed to compare ranibizumab in comparison with D...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01396057
Treatments Being Tested
The overarching goal of this Pain Management Collaboratory Demonstration pr...
Status
Completed
Location
SFVAHCS
Start Date
2020-09-15
Trial ID
NCT04330365
This study is a Phase III, double-masked, multicenter, randomized, sham inj...
Status
Terminated
Location
Associated Retina Consultants
Start Date
2014-10-06
Trial ID
NCT02247531
Treatments Being Tested
Safety and tolerability of three different concentrations (0.1%, 03%, 0.6%)...
Status
Completed
Location
Central Contact
Start Date
2017-05-10
Trial ID
NCT03131167
Treatments Being Tested
The main goal of this clinical trial is to evaluate the safety, tolerabilit...
Status
Completed
Location
CMAX Clinical Research
Start Date
2023-10-06
Trial ID
NCT05969236
Treatments Being Tested
This study is open to adults with diabetic macular ischemia who have receiv...
Status
Completed
Location
California Retina Consultants
Start Date
2021-07-30
Trial ID
NCT04919499
Treatments Being Tested
A study to evaluate the safety and efficacy of an FAI insert for the manage...
Status
Completed
Location
Retina Vitreaous Associates
Start Date
2013-08-02
Trial ID
NCT01694186
Treatments Being Tested
This study will evaluate the efficacy, safety, and PK of ranibizumab 100 mi...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-17
Trial ID
NCT05562947
Treatments Being Tested